These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 3032499

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Aldose reductase, glomerular metabolism, and diabetic nephropathy.
    Cohen MP.
    Metabolism; 1986 Apr; 35(4 Suppl 1):55-9. PubMed ID: 3007926
    [Abstract] [Full Text] [Related]

  • 3. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.
    Beyer-Mears A, Ku L, Cohen MP.
    Diabetes; 1984 Jun; 33(6):604-7. PubMed ID: 6427041
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Glomerular Na+-K+-ATPase activity in acute and chronic diabetes and with aldose reductase inhibition.
    Cohen MP, Klepser H.
    Diabetes; 1988 May; 37(5):558-62. PubMed ID: 2834250
    [Abstract] [Full Text] [Related]

  • 6. Na+-K+-ATPase pumping activity is not directly linked to myo-inositol levels after sorbinil treatment in lenses of diabetic rats.
    Yeh LA, Rafford CE, Goddu KJ, Ashton MA, Beyer TA, Hutson NJ.
    Diabetes; 1987 Dec; 36(12):1414-9. PubMed ID: 2824260
    [Abstract] [Full Text] [Related]

  • 7. Recent advances in the therapy of diabetic peripheral neuropathy by means of an aldose reductase inhibitor.
    Greene DA, Lattimer SA.
    Am J Med; 1985 Nov 15; 79(5A):13-7. PubMed ID: 3000175
    [Abstract] [Full Text] [Related]

  • 8. [Effects of M79175, an aldose reductase inhibitor, on experimental sugar cataracts].
    Ono H, Nozawa Y, Hayano S.
    Nippon Ganka Gakkai Zasshi; 1982 Nov 15; 86(9):1343-50. PubMed ID: 6818854
    [No Abstract] [Full Text] [Related]

  • 9. The effects of aldose reductase inhibition on nerve sorbitol and myoinositol concentrations in diabetic and galactosemic rats.
    Yue DK, Hanwell MA, Satchell PM, Handelsman DJ, Turtle JR.
    Metabolism; 1984 Dec 15; 33(12):1119-22. PubMed ID: 6438438
    [Abstract] [Full Text] [Related]

  • 10. Treatment with aldose reductase inhibitor or with myo-inositol arrests deterioration of the electroretinogram of diabetic rats.
    MacGregor LC, Matschinsky FM.
    J Clin Invest; 1985 Aug 15; 76(2):887-9. PubMed ID: 3928685
    [Abstract] [Full Text] [Related]

  • 11. Sorbinil suppresses glomerular prostaglandin production in the streptozotocin diabetic rat.
    Craven PA, DeRubertis FR.
    Metabolism; 1989 Jul 15; 38(7):649-54. PubMed ID: 2500578
    [Abstract] [Full Text] [Related]

  • 12. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
    Gillon KR, Hawthorne JN, Tomlinson DR.
    Diabetologia; 1983 Oct 15; 25(4):365-71. PubMed ID: 6416913
    [Abstract] [Full Text] [Related]

  • 13. Decreased myo-inositol content and Na+-K+-ATPase activity in superior cervical ganglion of STZ-diabetic rat and prevention by aldose reductase inhibition.
    Greene DA, Mackway AM.
    Diabetes; 1986 Oct 15; 35(10):1106-8. PubMed ID: 3019804
    [Abstract] [Full Text] [Related]

  • 14. Aldose reductase inhibition in diabetes.
    Clarke BF, Young RJ, Martyn CN, Ewing DJ.
    Diabet Med; 1984 Jul 15; 1(2):88-90. PubMed ID: 6242793
    [No Abstract] [Full Text] [Related]

  • 15. Effect of aldose reductase inhibitor on experimental diabetic cataract monitored by laser Raman spectroscopy.
    Mizuno A, Nozawa H, Yaginuma T, Matsuzaki H, Ozaki Y, Iriyama K.
    Exp Eye Res; 1987 Jul 15; 45(1):185-6. PubMed ID: 3115805
    [No Abstract] [Full Text] [Related]

  • 16. [Prevention of experimental diabetic corneal endotheliopathy with aldose reductase inhibitor].
    Akagi Y, Takahashi Y, Tanabe T, Ikebe H, Majima K, Miyatani H, Miyamoto Y, Terubayashi H.
    Nippon Ganka Gakkai Zasshi; 1987 Feb 15; 91(2):187-93. PubMed ID: 3111199
    [No Abstract] [Full Text] [Related]

  • 17. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A, Cruz E.
    Diabetes; 1985 Jan 15; 34(1):15-21. PubMed ID: 3917257
    [Abstract] [Full Text] [Related]

  • 18. Raman spectroscopic study of the effect of aldose reductase inhibitor on experimental diabetic cataract.
    Nozawa H, Yaginuma T, Mizuno A.
    Nippon Ganka Gakkai Zasshi; 1988 Jan 15; 92(1):194-201. PubMed ID: 3133929
    [No Abstract] [Full Text] [Related]

  • 19. Nonosmotic diabetic cataracts.
    Malone JI, Lowitt S, Cook WR.
    Pediatr Res; 1990 Mar 15; 27(3):293-6. PubMed ID: 2138728
    [Abstract] [Full Text] [Related]

  • 20. The effect of aldose reductase and its inhibition on sugar cataract formation.
    Kador PF, Akagi Y, Kinoshita JH.
    Metabolism; 1986 Apr 15; 35(4 Suppl 1):15-9. PubMed ID: 3083204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.